Irritable Bowel Syndrome News

Although it did not meet stringent recommended endpoints dictated by the FDA and European Medicines Agency, small intestinal-release peppermint oil reduced abdominal pain, discomfort and severity in patients with irritable bowel syndrome, according to study results.

In a post-marketing study, the manufacturer of IBgard showed that over-the-counter peppermint oil treatment effectively managed symptoms of irritable bowel syndrome without the side effect of heartburn.

Researchers from Beth Israel Deaconess Medical Center identified an overlap of gastrointestinal and psychosomatic symptoms between patients with diarrhea-predominant irritable bowel syndrome and functional diarrhea.

Although patients with diarrhea- and constipation-predominant irritable bowel syndrome tend to find their condition equally bothersome, they find their lives impacted in different ways, according to survey results.

Mayo Clinic tops U.S. News & World Report’s 2019-2020 Best Hospitals rankings for adult gastroenterology and gastrointestinal surgery.

Researchers cut a trial short after fecal microbiota transplantation failed to provide symptom relief better than that of placebo in patients with diarrhea-predominant irritable bowel syndrome.

Arena Pharmaceuticals announced that the first patient has been dosed in the phase 2 CAPTIVATE trial, according to a company press release.

Patients with irritable bowel syndrome and psychiatric comorbidities are more likely to seek psychiatric care but not gastrointestinal care when they also have extra-gastrointestinal symptoms, according to study results.

Several members of the American Gastroenterological Association recently met with representatives from the FDA’s Center for Biologics Evaluation and Research to offer clinical and research perspectives on fecal microbiota transplantation and to gain a better understanding of CBER’s thoughts on the regulation of FMT for Clostridioides difficile infection.

Researchers found that depression was independently associated with greater inflammatory bowel disease, or IBD, activity, and that less positive cognitive bias in emotional recognition partially mediated the effects of disease activity on depression.